HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuyuki Matsushita Selected Research

RNA (Ribonucleic Acid)

8/2020Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories.
3/2015Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuyuki Matsushita Research Topics

Disease

47Neoplasms (Cancer)
12/2023 - 07/2003
22Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 11/2002
10Esophageal Neoplasms (Esophageal Cancer)
04/2023 - 11/2005
8Esophageal Squamous Cell Carcinoma
12/2020 - 02/2006
7Stomach Neoplasms (Stomach Cancer)
04/2023 - 05/2011
7Neoplasm Metastasis (Metastasis)
02/2020 - 11/2002
5COVID-19
04/2024 - 08/2020
4Colonic Neoplasms (Colon Cancer)
04/2018 - 03/2011
4Hepatocellular Carcinoma (Hepatoma)
01/2016 - 08/2008
3Breast Neoplasms (Breast Cancer)
04/2023 - 01/2016
3Pancreatic Neoplasms (Pancreatic Cancer)
04/2023 - 01/2011
3Ischemic Stroke
01/2021 - 12/2020
3Atherosclerosis
01/2021 - 12/2020
3Chronic Renal Insufficiency
01/2021 - 04/2011
3Lung Neoplasms (Lung Cancer)
01/2018 - 01/2014
3Carcinogenesis
03/2015 - 02/2006
2Disease Progression
11/2023 - 12/2018
2Biliary Tract Neoplasms (Biliary Tract Cancer)
08/2021 - 01/2012
2Diabetes Mellitus
01/2021 - 12/2020
2Infections
01/2020 - 07/2014
2Dermatomyositis (Dermatopolymyositis)
06/2019 - 12/2016
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2018 - 09/2007
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
04/2018 - 01/2006
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2017 - 09/2015
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
09/2017 - 03/2015
2Lymphoma (Lymphomas)
09/2017 - 03/2015
2Carcinoma (Carcinomatosis)
01/2016 - 01/2006
2Graves Disease (Basedow Disease)
12/2015 - 12/2015
2Fibrosis (Cirrhosis)
06/2015 - 01/2015
2Pathologic Constriction (Stenosis)
06/2015 - 01/2015
2Hyperplasia
06/2015 - 01/2015
2Alzheimer Disease (Alzheimer's Disease)
08/2014 - 01/2014
2Periodontal Diseases (Periodontal Disease)
08/2013 - 07/2012
1Respiratory Insufficiency (Respiratory Failure)
04/2024
1Interstitial Lung Diseases (Interstitial Lung Disease)
04/2024
1Hypersensitivity (Allergy)
12/2021
1Microsatellite Instability
08/2021
1Transient Ischemic Attack
01/2021
1Myasthenia Gravis
01/2021

Drug/Important Bio-Agent (IBA)

24Proteins (Proteins, Gene)FDA Link
12/2022 - 07/2003
23Biomarkers (Surrogate Marker)IBA
11/2023 - 10/2009
12AntibodiesIBA
11/2023 - 07/2003
11AntigensIBA
02/2023 - 09/2003
10AutoantibodiesIBA
04/2023 - 07/2014
10Tumor Biomarkers (Tumor Markers)IBA
02/2023 - 03/2004
10poly-U binding splicing factor 60KDaIBA
09/2017 - 02/2006
9Messenger RNA (mRNA)IBA
12/2023 - 01/2006
6Indicators and Reagents (Reagents)IBA
11/2023 - 12/2012
6ImmunosorbentsIBA
04/2023 - 02/2009
6Complementary DNA (cDNA)IBA
02/2023 - 04/2018
6ElementsIBA
02/2020 - 06/2012
6Small Interfering RNA (siRNA)IBA
05/2018 - 03/2011
5Carrier Proteins (Binding Protein)IBA
02/2020 - 02/2013
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2010
4Cystatin CIBA
12/2015 - 04/2011
4CreatinineIBA
12/2015 - 04/2011
4ProteomeIBA
07/2012 - 03/2004
4Histone Deacetylase InhibitorsIBA
01/2010 - 11/2005
3Interleukin-6 (Interleukin 6)IBA
01/2021 - 10/2009
3Immunoglobulin G (IgG)IBA
01/2021 - 07/2014
3Peptides (Polypeptides)IBA
01/2021 - 05/2011
3Protein Isoforms (Isoforms)IBA
01/2017 - 03/2004
3Carcinoembryonic AntigenIBA
01/2016 - 05/2011
3EnzymesIBA
01/2016 - 02/2009
3Lipocalin-2IBA
08/2013 - 10/2009
3romidepsin (FK228)FDA Link
03/2008 - 11/2005
2EpitopesIBA
12/2022 - 07/2014
2Hematoxylin (Haematoxylon)IBA
08/2021 - 06/2015
2Eosine Yellowish-(YS) (Eosin)IBA
08/2021 - 06/2015
2Recombinant ProteinsIBA
01/2021 - 04/2018
2RNA (Ribonucleic Acid)IBA
08/2020 - 03/2015
2RNA Precursors (Precursor, mRNA)IBA
02/2020 - 06/2012
2Cyclin EIBA
02/2020 - 05/2018
2Cadherins (E-Cadherin)IBA
02/2020 - 03/2012
2Annexin A2 (Annexin II)IBA
10/2018 - 12/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2018 - 12/2010
2RNA Splicing FactorsIBA
05/2018 - 12/2016
2Poly UIBA
05/2018 - 12/2016
2CollagenIBA
06/2015 - 01/2015
2Apolipoproteins E (ApoE)IBA
08/2014 - 01/2014
2AlbuminsIBA
01/2014 - 10/2012
2CarbohydratesIBA
02/2013 - 05/2011
2Peptide Initiation Factors (Initiation Factor)IBA
03/2011 - 03/2004
2Vitamin D-Binding ProteinIBA
01/2011 - 10/2009
2Retinol-Binding Proteins (Retinoid Binding Proteins)IBA
01/2011 - 10/2009
2CarbonIBA
11/2010 - 01/2006
2Sepharose (Agarose)IBA
02/2006 - 03/2004
2HLA-DR Antigens (HLA-DR)IBA
01/2006 - 09/2003
1Ribosomal RNAIBA
12/2023
1Inhibitor of Growth Protein 1IBA
04/2023
1Amino AcidsFDA Link
02/2023
1HLA-A*24:02 antigenIBA
12/2022
1VaccinesIBA
11/2022
1BNT162 VaccineIBA
11/2022
1GlucocorticoidsIBA
12/2021

Therapy/Procedure

14Therapeutics
02/2021 - 11/2002
5Drug Therapy (Chemotherapy)
01/2020 - 11/2002
3Lasers (Laser)
01/2020 - 05/2011
2Lung Transplantation
04/2024 - 01/2020
1Transplantation
04/2024